Secondary prevention implantable cardioverter-defibrillator (ICD) therapy: value in octogenarians.

ABSTRACT:

Background

Implantable cardioverter-defibrillator (ICD) therapy is well established for secondary prevention, but studies on the efficacy and safety in elderly patients are still lacking. This retrospective study compared the outcome after ICD implantation between octogenarians and other age groups.

Methods

Data were obtained from a local ICD registry. Patients who received ICD implantation for secondary prevention at our department were included. All-cause mortality, appropriate ICD therapy and acute adverse events requiring surgical intervention were compared between different age groups.

Results

519 patients were enrolled, 34 of whom were aged ≥ 80 years. During the median follow-up of 35 months after ICD implantation 129 patients (annual mortality rate 5.0%) had d

SUBMITTER: Hauck C 

PROVIDER: S-EPMC9135875 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature